SCHEDULE 13G/A: BlackRock Boosts Stake in Masimo Corp, Now Holds 7.9% of Common Stock

BlackRock, Inc. has filed an amended Schedule 13G, disclosing an increased beneficial ownership of 7.9% in Masimo Corp's common stock as of January 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 4,231,142 shares of Masimo Corp common stock.
• This represents 7.9% of Masimo Corp's outstanding common stock.
• BlackRock holds sole voting power over 4,126,303 shares and sole dispositive power over 4,231,142 shares.
• The filing is an Amendment No. 5 to a Schedule 13G, indicating a change from a previous filing.
• BlackRock, Inc. is classified as a parent holding company (HC) for this filing.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Masimo Corp.
• BlackRock Fund Advisors, a subsidiary of BlackRock, Inc., beneficially owns 5% or greater of the outstanding shares of Masimo Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a 13G filing is primarily informational and not indicative of company performance, a large institutional investor like BlackRock increasing or maintaining a significant stake (7.9%) can be interpreted as a positive signal of confidence in the issuer's long-term value, especially given the certification that the shares are held in the ordinary course of business and not for control purposes.

Positives

• A significant stake (7.9%) held by a major institutional investor like BlackRock can signal confidence in Masimo Corp's long-term prospects.
• The filing indicates that BlackRock's acquisition of shares was in the ordinary course of business, suggesting a strategic investment rather than an activist stance.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Masimo Corp's future performance or outlook. It solely reports BlackRock's beneficial ownership stake.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." Spencer Fleming, Managing Director, BlackRock, Inc.

Industry Context

This filing reflects a routine disclosure by a major asset manager, BlackRock, regarding its passive investment in Masimo Corp, a company operating in the healthcare technology and medical device industry. Such filings are common and indicate ongoing portfolio adjustments by large institutional investors, rather than specific industry-wide trends, though a significant stake by a firm like BlackRock can be seen as a vote of confidence in the sector or the specific company.

Corporate Governance

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor like BlackRock may be viewed positively, potentially reinforcing investor confidence in Masimo Corp's stock.
• Management: Awareness of a large, passive institutional holder like BlackRock may influence management's strategic considerations, though BlackRock explicitly states its holdings are not for control purposes.

Key Dates

Recommendation

Keywords

Masimo Corp, BlackRock, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, Healthcare Technology, Medical Devices, Financial Filing, SEC